Vaccine Adverse Event Reporting and Monitoring

Vaccine adverse event reporting and monitoring is the post-licensure pharmacovigilance system that collects, classifies, and analyses health events that occur after immunization. It combines passive (spontaneous) reporting, which captures unsolicited reports from clinicians and the public, with active surveillance in defined populations that can estimate event rates, so that rare or unexpected safety signals can be detected and evaluated. This entry describes how these systems work and what they can and cannot establish.

Definition

The organized collection, standardized classification, and analysis of adverse events following immunization through spontaneous reporting and active surveillance systems, used to detect, characterize, and evaluate potential vaccine safety signals after a vaccine is licensed.

Scope

The entry covers the architecture of vaccine safety surveillance: spontaneous reporting systems and their role in hypothesis generation; active, population-based surveillance using linked electronic health records; standardized Brighton Collaboration case definitions that make events comparable; and causality assessment that interprets reported events against expected background rates. It is a methodological reference and does not constitute reporting instructions or clinical guidance for any individual case.

Core questions

• What is the difference between passive (spontaneous) reporting and active surveillance?
• How do standardized case definitions improve the comparability of reported events?
• How are observed event rates compared with expected background rates to evaluate a signal?
• Why can spontaneous reports generate hypotheses but not by themselves establish causation or incidence?

Key concepts

• Spontaneous (passive) reporting system
• Active vaccine safety surveillance
• Adverse event following immunization (AEFI)
• Brighton Collaboration case definitions
• Safety signal detection
• Observed-to-expected analysis
• Background (expected) rate
• Causality assessment
• Reporting and ascertainment bias

Mechanisms

Passive systems receive unsolicited reports of events that follow vaccination; because they capture a very large and diverse stream of reports, they are well suited to detecting rare and previously unrecognized events and to generating hypotheses, but they cannot by themselves estimate how often an event occurs (shimabukuro-2015). Active surveillance in defined populations, often using linked electronic health records, counts events among known numbers of vaccinees and compares observed rates with expected background rates, allowing quantitative evaluation of a signal (klein-2021). Standardized case definitions developed by the Brighton Collaboration make reported events comparable across systems and countries (ruggeberg-2007, sejvar-2007), and structured causality assessment then interprets the evidence before an event is attributed to a vaccine (who-aefi-2013).

Clinical relevance

Adverse event reporting and monitoring is the means by which the safety profile of a vaccine is refined after licensure and by which rare reactions are detected and quantified; understanding it is part of evidence appraisal in immunization. The entry explains how surveillance generates and evaluates safety signals at the population level and does not provide instructions for managing or reporting any individual patient's event, which follow local regulatory and clinical procedures.

Epidemiology

Surveillance systems process large volumes of reports, the great majority of which describe mild, self-limited events, against a background in which serious vaccine-attributable events are rare. Active surveillance across millions of vaccinees allows even uncommon events to be assessed by comparing observed and expected rates (klein-2021), while passive systems provide breadth and early warning (shimabukuro-2015).

History

National spontaneous reporting systems for vaccine adverse events were established to provide post-licensure safety monitoring, and their structure and uses were summarized for the largest such system in the mid-2010s (shimabukuro-2015). The Brighton Collaboration standardized case definitions in the 2000s so that events such as anaphylaxis and neurological syndromes could be compared internationally (ruggeberg-2007, sejvar-2007), and the World Health Organization revised its causality-assessment framework to interpret reported events more rigorously (who-aefi-2013). Large active-surveillance studies during recent vaccination campaigns illustrated the complementary role of population-based monitoring (klein-2021).

Debates

Limits of spontaneous reporting

Passive systems are subject to under-reporting and reporting bias and cannot establish incidence or causation on their own, so signals they raise require confirmation through active surveillance and observed-to-expected analysis.

Standardization of case definitions

Without harmonized definitions, the same clinical event may be reported and counted differently across systems, which is why Brighton Collaboration definitions were developed to enable consistent comparison.

Seminal works

• shimabukuro-2015
• ruggeberg-2007
• who-aefi-2013

Frequently asked questions

Does a report to a vaccine safety system mean the vaccine caused the event?

No. A report records that an event occurred after vaccination; many such events are coincidental, and establishing causation requires comparing observed rates with expected background rates and applying structured causality assessment.

Why are both passive and active surveillance systems used?

Passive reporting is broad and sensitive to rare or unexpected events and so generates hypotheses, while active surveillance in defined populations can estimate event rates and test those hypotheses; together they provide more complete safety monitoring.